Clinical Trial Update: A Study of RO5028442 in Adult Male High-Functioning Autistic Patients [Phase 1]

View source ↗

Summary

Phase 1 trial of RO5028442 in adult male high-functioning autism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• RO5028442

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Autistic Disorder | Phase 1 | Status: COMPLETED